Inflammatory breast cancer (IBC) is a rare form of breast cancer that accounts for only about
2% to 4% of all breast cancer cases in the United States. 1 Despite its low incidence, IBC …

In the absence of histological criteria that distinguish between inflammatory and non-
inflammatory breast cancer, diagnosis of inflammatory breast cancer relies entirely on the …

Breast cancer is associated with high mortality due to tumor metastasis. The anti-metastasis
efficacy of photochemotherapy is strictly limited by poor targeting capability with respect to …

The enumeration of circulating tumor cells (CTCs) provides important prognostic values in
patients with metastatic breast cancer. Recent studies indicate that individual CTCs form …

Abstract Inflammatory Breast Cancer (IBC) is a highly aggressive malignancy with distinct
clinical and histopathological features whose molecular basis is unresolved. Here we …

Our understanding is limited concerning the tumor immune microenvironment of
inflammatory breast cancer (IBC), an aggressive form of primary cancer with low rates of …

Inflammatory breast cancer is a rare and aggressive malignancy that is often initially
misdiagnosed because of its similar presentation to more benign breast pathologies such as …

The RNA polypyrimidine tract-binding protein PTBP3 is a little studied paralog of PTBP1,
which has oncogenic properties. In this study, we demonstrate that PTBP3 induces epithelial …

Background Inflammatory breast cancer (IBC) is a very aggressive and lethal subtype of
breast cancer that accounts for about 4% of all breast cancers diagnosed in the United …

Background Inflammatory breast cancer (IBC) is a rare and aggressive disease, accounting
for 2–4% of new cases of breast cancer. Owing to its aggressive nature, IBC represent …